-
Filing menu
Jump to…
Sign up to personalize
- Track your favorite companies
- Receive emails for new filings
- Personalized dashboard of news and more
- In-app alert feed to stay updated
- Create and share research notes
- Annotate filings and transcripts
Filing files
SEC
IPIX 8-K filings
- 19 Jun 20 Regulation FD Disclosure
- 26 May 20 Innovation Pharmaceuticals Receives Data from Public Health Research Institute Showing Brilacidin Inhibits SARS-CoV-2 (COVID-19) in a Human Cell Line
- 21 May 20 Regulation FD Disclosure
- 28 Apr 20 Innovation Pharmaceuticals Informed Next Phase of Brilacidin Coronavirus (COVID-19) Testing to Begin Week of May 4
- 6 Apr 20 Regulation FD Disclosure
- 1 Apr 20 Innovation Pharmaceuticals Receives Data Supporting Brilacidin’s Direct Inhibition of SARS-CoV-2, the Novel Coronavirus Responsible for COVID-19
- 6 Mar 20 Innovation Pharmaceuticals Signs Second MTA to Explore Brilacidin as Coronavirus
Filing view
Search this filing
Table of contents
- IPIX Dashboard
- Financials
- Data
- Institutional
- Insider
- News
- Filings
- ESG
- Patents
-
8-K Filing